moxisylyte has been researched along with Leriche Syndrome in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Leriche Syndrome: A condition caused by occlusion of terminal aorta, the primary branches of the ABDOMINAL AORTA, as in aortoiliac obstruction. Leriche syndrome usually occurs in males and is characterized by IMPOTENCE, absence of a pulse in the femoral arteries, weakness and numbness in the lower back, buttocks, hips, and lower limbs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghiglino, GC | 1 |
| Viacava, A | 1 |
| Gori, A | 1 |
| Misuri, A | 1 |
| Lucertini, G | 1 |
| Pelagatti, M | 1 |
1 other study available for moxisylyte and Leriche Syndrome
| Article | Year |
|---|---|
[Clinical use of thymoxamine in peripheral arterial pathology].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Leg; Leriche Syndrome; Male; Middle Aged; | 1983 |